WallStreetZenWallStreetZen

NASDAQ: GLSI
Greenwich Lifesciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

GLSI earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$8.9M
Current Profit Margin
0%

GLSI Return on Equity

Current Company
-93.9%
Current Industry
-63.5%
Current Market
188%
GLSI's Return on Equity (-93.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when GLSI announces earnings.

GLSI Return on Assets

Current Company
-91.2%
Current Industry
2.9%
GLSI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GLSI Return on Capital Employed

Current Company
-132.71%
Current Industry
19.5%
GLSI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GLSI vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GLSI$0.00-$8.89M-$8.89MN/AN/A
SCPH$13.59M-$46.06M-$54.81MN/AN/A
MDWD$18.69M-$3.34M-$6.72M+40.60%N/A
PRQR$10.35M-$26.33M-$30.56M+9.83%N/A
OBIO$2.76M-$48.20M-$49.12M-80.21%N/A
View Top Biotech Stocks

GLSI earnings dates

Next earnings date
May 22, 2024

Greenwich Lifesciences Earnings & Revenue FAQ

What were GLSI's earnings last quarter?

On Invalid Date, Greenwich Lifesciences (NASDAQ: GLSI) reported Q4 2023 earnings per share (EPS) of -$0.21, up 4.55% year over year. Total Greenwich Lifesciences earnings for the quarter were -$2.75 million. In the same quarter last year, Greenwich Lifesciences's earnings per share (EPS) was -$0.22.

If you're new to stock investing, here's how to buy Greenwich Lifesciences stock.

What was GLSI's earnings growth in the past year?

As of Q2 2024, Greenwich Lifesciences's earnings has grown year over year. Greenwich Lifesciences's earnings in the past year totalled -$8.89 million.

What is GLSI's earnings date?

Greenwich Lifesciences's earnings date is Invalid Date. Add GLSI to your watchlist to be reminded of GLSI's next earnings announcement.

What was GLSI's revenue last quarter?

On Invalid Date, Greenwich Lifesciences (NASDAQ: GLSI) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Greenwich Lifesciences's revenue was $0.00.

What was GLSI's revenue growth in the past year?

As of Q2 2024, Greenwich Lifesciences's revenue has grown null year over year. Greenwich Lifesciences's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.